Imatinib Terminated Phase 1 Trials for Blastic Phase Chronic Myelogenous Leukemia / Relapsing Chronic Myelogenous Leukemia / Accelerated Phase Chronic Myelogenous Leukemia / Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Chronic Phase Chronic Myelogenous Leukemia Treatment